EDITORIAL
Published on 30 Nov 2022
Editorial: Women in pharmacology of anti-cancer drugs: 2021
doi 10.3389/fphar.2022.1092204
- 815 views
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Women in Pharmacology of Anti-Cancer Drugs: 2021
Women in Pharmacology of Anti-Cancer Drugs: 2021
7,692
Total downloads
23k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 04 Oct 2022
Patient-associated risk factors for severe anemia in patients with advanced ovarian or breast cancer receiving olaparib monotherapy: A multicenter retrospective study
doi 10.3389/fonc.2022.898150
- 3,663 views
- 7 citations
MINI REVIEW
Published on 24 May 2022
Curcumin and Related Compounds in Cancer Cells: New Avenues for Old Molecules
doi 10.3389/fphar.2022.889816
- 4,468 views
- 23 citations
ORIGINAL RESEARCH
Published on 12 May 2022
Cinnamaldehyde Suppressed EGF-Induced EMT Process and Inhibits Ovarian Cancer Progression Through PI3K/AKT Pathway
doi 10.3389/fphar.2022.779608
- 3,012 views
- 26 citations
ORIGINAL RESEARCH
Published on 05 Apr 2022
Cinobufacini Injection Inhibits the Proliferation of Triple-Negative Breast Cancer Through the Pin1–TAZ Signaling Pathway
doi 10.3389/fphar.2022.797873
- 2,223 views
- 10 citations
ORIGINAL RESEARCH
Published on 21 Mar 2022
Efficacy and Pharmacological Mechanism of Poria cocos-Based Formulas Combined With Chemotherapy for Ovarian Cancer: A Integrated Systems Pharmacology Study
doi 10.3389/fphar.2022.788810
- 3,768 views
- 6 citations
ORIGINAL RESEARCH
Published on 08 Nov 2021
Quantitative Analysis of the Efficacy of PARP Inhibitors as Maintenance Therapy in Recurrent Ovarian Cancer
doi 10.3389/fphar.2021.771836
- 1,975 views
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore